NFKB1 and neoplasm: Additionally, sublytic levels of MAC deposition can activate intracellular signaling pathways, including PI3K/Akt, MAPK/Erk, and NF-κB/STAT3, leading to enhanced tumor cell proliferation, survival, and upregulation of drug efflux transporters [50,51,52].